Obesity increases histone H3 lysine 9 and 18 acetylation at Tnfa and Ccl2 genes in mouse liver

International Journal of Molecular Medicine

Volumn 34, Issue 6, 2014, Pages 1647-1654

  Mikula, Michal ^a   Majewska, Aneta ^b   Ledwon, Joanna Karolina ^b   Dzwonek, Artur ^a   Ostrowski, Jerzy ^a,b  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Chromatin immuno precipitation; Histone H3 acetylation; Inflammation; Lipopolysaccharides; Liver steatosis

Indexed keywords

HISTONE H3; HISTONE H3 LYSINE 18; HISTONE H3 LYSINE 9; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA POLYMERASE II; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CCL2 PROTEIN, MOUSE; DNA DIRECTED DNA POLYMERASE ALPHA; HISTONE; LYSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CCL2 GENE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPIGENETICS; FATTY LIVER; GENE; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HYPERPHAGIA; IN VITRO STUDY; INFLAMMATION; LIPID DIET; LIVER CELL; MALE; MOUSE; MURINE MODEL; NONHUMAN; OBESITY; TNFA GENE; ACETYLATION; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; LIVER; METABOLISM; MOUSE MUTANT; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ACETYLATION; ANIMALS; CELL LINE, TUMOR; CHEMOKINE CCL2; CHROMATIN IMMUNOPRECIPITATION; DIET, HIGH-FAT; DNA POLYMERASE II; FATTY LIVER; GENE EXPRESSION; HISTONES; LIPOPOLYSACCHARIDES; LIVER; LYSINE; MALE; MICE, INBRED C57BL; MICE, OBESE; NF-KAPPA B; OBESITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908059562     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1958     Document Type: Article

References (45)

1. Larter CZ and Yeh MM: Animal models of NASH: getting both pathology and metabolic context right. J Gastroenterol Hepatol 23: 1635-1648, 2008.
2. Hotamisligil GS: Inflammation and metabolic disorders. Nature 444: 860-867, 2006.
3. Curat CA, Miranville A, Sengenès C, Diehl M., Tonus C, Busse R and Bouloumié A: From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 53: 1285-1292, 2004.
4. Kamei N, Tobe K, Suzuki R., et al: Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281: 26602-26614, 2006.
5. Musso G, Gambino R and Cassader M: Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care 33: 2277-2284, 2010.
6. Moreno-Indias I., Cardona F, Tinahones FJ and Queipo-Ortuño MI: Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol 5: 190, 2014.
7. Cani PD and Delzenne NM: The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 15: 1546-1558, 2009.
8. Nesteruk M, Hennig EE, Mikula M, et al: Mitochondrial-related proteomic changes during obesity and fasting in mice are greater in the liver than skeletal muscles. Funct Integr Genomics 14: 245-259, 2014.
9. Hennig EE, Mikula M, Goryca K., et al: Extracellular matrix and cytochrome P450 gene expression can distinguish steatohepatitis from steatosis in mice. J Cell Mol Med 18: 1762-1772, 2014.
10. Prinjha R and Tarakhovsky A: Chromatin targeting drugs in cancer and immunity. Genes Dev 27: 1731-1738, 2013.
11. Bannister AJ and Kouzarides T: Regulation of chromatin by histone modifications. Cell Res 21: 381-395, 2011.
12. Kouzarides T: Chromatin modifications and their function. Cell 128: 693-705, 2007.
13. Dahl JA and Collas P: MicroChIP: chromatin immunoprecipita-tion for small cell numbers. Methods Mol Biol 567: 59-74, 2009.
14. Flanagin S, Nelson JD, Castner D.G., Denisenko O and Bomsztyk K: Microplate-based chromatin immunoprecipitation method, Matrix ChIP: a platform to study signaling of complex genomic events. Nucleic Acids Res 36: e17, 2008.
15. Bomsztyk K, Flanagin S, Mar D., Mikula M, Johnson A, Zager R and Denisenko O: Synchronous recruitment of epigenetic modifiers to endotoxin synergistically activated Tnf-α gene in acute kidney injury. PLoS ONE 8: e70322, 2013.
16. Yu J, Feng Q, Ruan Y., Komers R, Kiviat N and Bomsztyk K: Microplate-based platform for combined chromatin and DNA methylation immunoprecipitation assays. BMC Mol Biol 12: 49, 2011.
17. Vandesompele J, De Preter K, Pattyn F, Poppe B., Van Roy N, De Paepe A and Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034, 2002.
18. Tian Y, Wong VWS, Chan HLY and Cheng ASL: Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease. Semin Cancer Biol 23: 471-482, 2013.
19. Lawrence T: The nuclear factor NF-kappaB pathway in inflam-mation. Cold Spring Harb Perspect Biol 1: a001651, 2009.
20. Medzhitov R and Horng T: Transcriptional control of the inflam-matory response. Nat Rev Immunol 9: 692-703, 2009.
21. Freaney JE, Kim R, Mandhana R and Horvath CM: Extensive cooperation of immune master regulators IRF3 and NF-κB in RNA Pol II recruitment and pause release in human innate antiviral transcription. Cell Rep 4: 959-973, 2013.
22. Martone R, Euskirchen G, Bertone P., et al: Distribution of NF-kappaB-binding sites across human chromosome 22. Proc Natl Acad Sci USA 100: 12247-12252, 2003.
23. Shanmugam MK and Sethi G: Role of epigenetics in inflamma-tion-associated diseases. Subcell Biochem 61: 627-657, 2013.
24. Naik A, Košir R and Rozman D: Genomic aspects of NAFLD pathogenesis. Genomics 102: 84-95, 2013.
25. Kim Y and Park T: DNA microarrays to define and search for genes associated with obesity. Biotechnol J 5: 99-112, 2010.
26. Xu C, Wang G, Hao Y., Zhi J, Zhang L and Chang C: Correlation analysis between gene expression profile of rat liver tissues and high-fat emulsion-induced nonalcoholic fatty liver. Dig Dis Sci 56: 2299-2308, 2011.
27. Nishida T, Tsuneyama K, Fujimoto M., et al: Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome. Lab Invest 93: 230-241, 2013.
28. Stanton MC, Chen SC, Jackson J V, et al: Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice. J Inflamm (Lond) 8: 8, 2011.
29. Semaan N, Frenzel L, Alsaleh G., et al: miR-346 controls release of TNF-α protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization. PLoS ONE 6: e19827, 2011.
30. Deleault KM, Skinner SJ and Brooks SA: Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways. Mol Immunol 45: 13-24, 2008.
31. Li Z, Chao TC, Chang K.Y., et al: The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proc Natl Acad Sci USA 111: 1002-1007, 2014.
32. Naito M, Bomsztyk K and Zager RA: Endotoxin mediates recruitment of RNA polymerase II to target genes in acute renal failure. J Am Soc Nephrol 19: 1321-1330, 2008.
33. Struhl K: Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12: 599-606, 1998.
34. Shebzukhov Y.V., Horn K, Brazhnik K.I., Drutskaya MS, Kuchmiy AA, Kuprash DV and Nedospasov SA: Dynamic changes in chromatin conformation at the TNF transcription start site in T helper lymphocyte subsets. Eur J Immunol 44: 251-264, 2014.
35. Miao F, Gonzalo IG, Lanting L and Natarajan R: In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 279: 18091-18097, 2004.
36. Sullivan KE, Reddy ABM, Dietzmann K, Suriano A.R., Kocieda V P, Stewart M and Bhatia M: Epigenetic regulation of tumor necrosis factor alpha. Mol Cell Biol 27: 5147-5160, 2007.
37. Garrett S, Dietzmann-Maurer K, Song L and Sullivan KE: Polarization of primary human monocytes by IFN-gamma induces chromatin changes and recruits RNA Pol II to the TNF-alpha promoter. J Immunol 180: 5257-5266, 2008.
38. Falvo J.V., Tsytsykova AV and Goldfeld AE: Transcriptional control of the TNF gene. In: Current Directions in Autoimmunity. Vol. 11. Kollias G and Sfikakis PP (eds.) Karger, Basel, pp 27-60, 2010.
39. Nicodeme E, Jeffrey KL, Schaefer U, et al: Suppression of inflam-mation by a synthetic histone mimic. Nature 468: 1119-1123, 2010.
40. Wang F, Liu H, Blanton W P, Belkina A, Lebrasseur NK and Denis GV: Brd2 disruption in mice causes severe obesity without Type 2 diabetes. Biochem J 425: 71-83, 2010.
41. Wang F, Deeney JT and Denis GV: Brd2 gene disruption causes 'metabolically healthy' obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes. Vitam Horm 91: 49-75, 2013.
42. Belkina AC and Denis GV: BET domain co-regulators in obesity, inflammation and cancer. Nat Rev Cancer 12: 465-477, 2012.
43. Zhang Y and Reinberg D: Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev 15: 2343-2360, 2001.
44. Shilatifard A: Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem 75: 243-269, 2006.
45. Zhang H, Gao L, Anandhakumar J and Gross DS: Uncoupling transcription from covalent histone modification. PLoS Genet 10: e1004202, 2014.